AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TIRZEPATIDE
20 registrations across 2 African markets— 20 active
Markets with TIRZEPATIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Tiza-Q 12.5 mg/0.5 ml PFS Injection Solution For Injection | 🇰🇪Kenya | QPHARMA DMCC | active | Mar 2031 |
| Tiza-Q 15 mg/0.5 ml PFS Injection Solution For Injection | 🇰🇪Kenya | QPHARMA DMCC | active | Mar 2031 |
| Zepad 5mg/0.5mL Injection Solution For Injection | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Mar 2031 |
| Zepad 2.5mg/0.5mL Injection. Solution For Injection | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Mar 2031 |
| Zepad 7.5mg/0.5mL Injection Solution For Injection | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Mar 2031 |
| Ovizep 5mg Solution for Injection Solution For Injection In Pre-Filled Pen | 🇰🇪Kenya | DAWA LIMITED | active | Jul 2030 |
| OVIZEP 2.5mg Solution for Injection Solution For Injection | 🇰🇪Kenya | Dawa Limited | active | Jul 2030 |
| Ovizep 7.5mg solution for Injection Solution For Injection | 🇰🇪Kenya | DAWA LIMITED | active | Jul 2030 |
| MOUNJARO 2,5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| MOUNJARO 15 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| MOUNJARO 7,5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| MOUNJARO 10 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| MOUNJARO 12,5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| PERSOVANCE 10 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| PERSOVANCE 12,5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| PERSOVANCE 15 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| PERSOVANCE 2,5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| PERSOVANCE 5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| MOUNJARO 5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
| PERSOVANCE 7,5 mg | 🇿🇦South Africa | Eli Lilly (S.A.) (Pty) Ltd | active | Apr 2029 |
TIRZEPATIDE in Africa — Regulatory Overview
TIRZEPATIDE is registered across 2 African markets with 20 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 20 registrations, 20 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.